Statistics for Regeneron Pharmaceuticals (id:7069 REGN)

Valuation metrics

Market cap

81.10B

Enterprise value

73.01B

Trailing P/E (ttm)

18.25

Forward P/E

16.29

PEG ratio

16.29

Price/Sales (ttm)

5.86

Price/Book (mrq)

2.71

Enterprise Value/Revenue

5.27

Enterprise Value/EBITDA

15.88

Overview

Shares outstanding

108.07M

Float

103.10M

Shares short

1.85M

% Held by insiders

0.02%

% Held by institutions

0.91%

Average volume (10 days)

897.76K

Average volume (90 days)

Price summary

52-Week low

735.95

52-Week high

1.21K

52-Week change

-8.15%

Beta

0.14

50-Day moving average

953.36

200-Day moving average

1.00K

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

33.61%

Operating margin

33.43%

Operational effectiveness

Return on assets

7.41%

Return on equity

17.17%

Income statement

Revenue (ttm)

128.69

Revenue per share (ttm)

128.69

Quarterly revenue growth (yoy)

0.33

Gross profit (ttm)

11.30B

EBITDA

5.24B

Net income to common (ttm)

4.65B

Diluted EPS (ttm)

40.43

Quarterly earnings growth (yoy)

33.00%

Balance sheet

Total cash (mrq)

9.80B

Total cash per share (mrq)

91.05

Total debt (mrq)

2.70B

Total Debt/Equity (mrq)

9.22

Current ratio (mrq)

528.10%

Book value per share (mrq)

272.04

Cash flow

Cash flow statement

4.25B

Levered free cash flow (LFCF)

2.25B